Abstract
The mechanism behind hormone dependent growth of breast cancer is presently not well understood. We show that the HES-1 protein level in the breast cancer cell lines T47D and MCF-7 is down regulated by 17β-estradiol treatment. This regulation could be reversed by addition of the anti-estrogens 4OH tamoxifen, raloxifen and Imperial Chemical Industries (ICI) 182,780. In T47D cells with inducible exogenous HES-1 expression, induced expression of HES-1 protein prevented the proliferative effect of 17β-estradiol and subsequent up regulation of proliferating cell nuclear antigen (PCNA). An inverse correlation between the HES-1 and PCNA protein levels respectively was found in colon cancer cell lines. These findings point to a potential role of HES-1 as a tumor suppressor in epithelial cells, and as a mediator of 17β-estradiols proliferative effect on breast cancer cells.
Original language | English (US) |
---|---|
Pages (from-to) | 5951-5953 |
Number of pages | 3 |
Journal | Oncogene |
Volume | 19 |
Issue number | 51 |
DOIs | |
State | Published - Nov 30 2000 |
Keywords
- 17β-estradiol
- Antiestrogen
- HES-1
- PCNA
- Proliferation
ASJC Scopus subject areas
- Molecular Biology
- Cancer Research
- Genetics